A detailed history of Janney Montgomery Scott LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 282,040 shares of LLY stock, worth $224 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
282,040
Previous 277,200 1.75%
Holding current value
$224 Million
Previous $251 Million 0.44%
% of portfolio
0.7%
Previous 0.77%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $3.74 Million - $4.65 Million
4,840 Added 1.75%
282,040 $250 Million
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $27.2 Million - $34.1 Million
-37,516 Reduced 11.92%
277,200 $251 Million
Q1 2024

May 01, 2024

BUY
$592.2 - $792.28 $29.8 Million - $39.9 Million
50,367 Added 19.05%
314,716 $245 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $5.42 Million - $6.39 Million
-10,328 Reduced 3.76%
264,349 $154 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $7.85 Million - $10.8 Million
18,048 Added 7.03%
274,677 $148 Million
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $4.17 Million - $5.58 Million
11,896 Added 4.86%
256,629 $120 Million
Q1 2023

Apr 28, 2023

BUY
$310.63 - $364.82 $3.37 Million - $3.96 Million
10,853 Added 4.64%
244,733 $84 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $4.12 Million - $4.8 Million
12,816 Added 5.8%
233,880 $85.6 Million
Q3 2022

Oct 25, 2022

SELL
$296.48 - $337.87 $813,837 - $927,453
-2,745 Reduced 1.23%
221,064 $71.5 Million
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $4.21 Million - $4.94 Million
-15,087 Reduced 6.32%
223,809 $71.5 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $609,255 - $757,149
2,596 Added 1.1%
238,896 $68.4 Million
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $1.19 Million - $1.48 Million
-5,297 Reduced 2.19%
236,300 $65.3 Million
Q3 2021

Oct 29, 2021

BUY
$221.6 - $272.71 $567,960 - $698,955
2,563 Added 1.07%
241,597 $55.8 Million
Q2 2021

Jul 26, 2021

SELL
$180.55 - $233.54 $2.08 Million - $2.69 Million
-11,536 Reduced 4.6%
239,034 $54.9 Million
Q1 2021

Apr 27, 2021

SELL
$164.32 - $212.72 $852,327 - $1.1 Million
-5,187 Reduced 2.03%
250,570 $46.8 Million
Q4 2020

Jan 25, 2021

BUY
$130.46 - $172.63 $1.38 Million - $1.83 Million
10,579 Added 4.31%
255,757 $43.2 Million
Q3 2020

Nov 06, 2020

SELL
$146.22 - $169.13 $440,414 - $509,419
-3,012 Reduced 1.21%
245,178 $36.3 Million
Q2 2020

Jul 23, 2020

BUY
$136.42 - $164.18 $2.9 Million - $3.49 Million
21,238 Added 9.36%
248,190 $40.7 Million
Q1 2020

Apr 30, 2020

BUY
$119.05 - $147.35 $2.3 Million - $2.85 Million
19,316 Added 9.3%
226,952 $31.5 Million
Q4 2019

Jan 21, 2020

SELL
$106.92 - $132.43 $2.8 Million - $3.46 Million
-26,145 Reduced 11.18%
207,636 $27.3 Million
Q3 2019

Oct 29, 2019

BUY
$106.79 - $116.16 $819,399 - $891,295
7,673 Added 3.39%
233,781 $26.1 Million
Q2 2019

Jul 29, 2019

BUY
$110.79 - $129.32 $348,212 - $406,452
3,143 Added 1.41%
226,108 $25.1 Million
Q1 2019

Apr 30, 2019

BUY
$111.31 - $131.02 $968,953 - $1.14 Million
8,705 Added 4.06%
222,965 $28.9 Million
Q4 2018

Feb 01, 2019

BUY
$105.9 - $118.64 $474,432 - $531,507
4,480 Added 2.14%
214,260 $24.8 Million
Q3 2018

Nov 05, 2018

SELL
$85.86 - $107.31 $635,278 - $793,986
-7,399 Reduced 3.41%
209,780 $22.5 Million
Q2 2018

Jul 24, 2018

SELL
$75.7 - $86.88 $160,938 - $184,706
-2,126 Reduced 0.97%
217,179 $18.5 Million
Q1 2018

Apr 19, 2018

SELL
$74.21 - $87.6 $319,696 - $377,380
-4,308 Reduced 1.93%
219,305 $17 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $1.29 Million - $1.39 Million
15,791 Added 7.6%
223,613 $18.9 Million
Q3 2017

Nov 15, 2017

BUY
$77.07 - $85.54 $16 Million - $17.8 Million
207,822
207,822 $17.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.